Ascendis Pharma A (ASND) Net Margin (2014 - 2026)
Ascendis Pharma A (ASND) reported Net Margin of 256.45% for Q1 2026, up 35025.0% on a YoY basis from N/an in Q1 2025, and up 3236.31% sequentially from 8.18% in Q4 2025.
Ascendis Pharma A (ASND) Net Margin (2014 - 2026) Analysis & Trends
Ascendis Pharma A (ASND) has 13 years of Net Margin data on file, last reported at 256.45% in Q1 2026.
- For the quarter ending Q1 2026, Net Margin rose 35025.0% year-over-year to 256.45%; the trailing twelve-month figure through Mar 2026 stood at 48.42% (up 7285.0% YoY), and the FY2025 full-year result was 32.16%, up 6102.0% from the prior year.
- Net Margin grew to 256.45% in Q1 2026, from 8.18% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 303.85% in Q2 2024 to a low of 1837.99% in Q1 2022.
- A 5-year average of 310.62% and a median of 29.29% in 2025 frame the typical range for Net Margin.
- Peak annual rise in Net Margin reached 657917 bps in 2022, while the deepest fall reached 1448054 bps in 2022.
- Tracing ASND's Net Margin over 5 years: stood at 905.96% in 2022, then jumped by 97 bps to 29.19% in 2023, then surged by 57 bps to 12.41% in 2024, then surged by 34 bps to 8.18% in 2025, then surged by 3236 bps to 256.45% in 2026.
- Business Quant data shows ASND's Net Margin at 256.45% in Q1 2026, 8.18% in Q4 2025, and 29.29% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 15.02% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 34.53% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 20.17% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 30.33% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Ascendis Pharma A | 15.31 Bn | 14.64 Bn | 268.20 Mn | 256.45% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 256.45% |
| Dec 31, 2025 | -8.18% |
| Sep 30, 2025 | -29.29% |
| Jun 30, 2025 | -25.47% |
| Mar 31, 2025 | -93.81% |
| Dec 31, 2024 | -12.41% |
| Sep 30, 2024 | -171.52% |
| Jun 30, 2024 | 303.85% |
| Mar 31, 2024 | 136.65% |
| Dec 31, 2023 | -29.19% |
| Sep 30, 2023 | -337.73% |
| Jun 30, 2023 | 258.37% |
| Mar 31, 2023 | -332.55% |
| Dec 31, 2022 | -905.96% |
| Sep 30, 2022 | -1,119.44% |
| Jun 30, 2022 | -1,332.40% |
| Mar 31, 2022 | -1,837.99% |
| Dec 31, 2021 | -123.14% |
| Sep 30, 2021 | 7,219.05% |
| Jun 30, 2021 | 13,148.14% |